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Abstract
SORCS1 and SORCS3 are two related sorting receptors expressed in
neurons of the arcuate nucleus of the hypothalamus. Using mouse
models with individual or dual receptor deficiencies, we document
a previously unknown function of these receptors in central
control of metabolism. Specifically, SORCS1 and SORCS3 act as
intracellular trafficking receptors for tropomyosin-related kinase B
to attenuate signaling by brain-derived neurotrophic factor, a
potent regulator of energy homeostasis. Loss of the joint action of
SORCS1 and SORCS3 in mutant mice results in excessive produc-
tion of the orexigenic neuropeptide agouti-related peptide and in
a state of chronic energy excess characterized by enhanced food
intake, decreased locomotor activity, diminished usage of lipids as
metabolic fuel, and increased adiposity, albeit at overall reduced
body weight. Our findings highlight a novel concept in regulation
of the melanocortin system and the role played by trafficking
receptors SORCS1 and SORCS3 in this process.
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Introduction
VPS10P domain receptors are a unique class of sorting receptors
that direct the intracellular transport of target proteins between
Golgi, cell surface, and endosomes in mammalian cell types. Sorted
cargo includes enzymes, growth factors, and signaling receptors,
implicating VPS10P domain receptors in vital cellular functions (re-
viewed in ref. [1]). Earlier work has largely focused on a role of
VPS10P domain receptors in control of protein transport in neurons,
and its relevance for functional integrity but also diseases of the
brain, including Alzheimer and Huntington disease, frontotemporal
lobar dementia, and schizophrenia (reviewed in ref. [2]). However,
genomewide investigations in humans and animal models have also
associated VPS10P domain receptors with disorders of the systemic
metabolism, including hypercholesterolemia [3], diabetes [4–6], and
obesity [7,8], suggesting involvement of these receptors in control
of metabolism that warrants further clarification.
Sorting-related receptor CNS expressed (SORCS) 1 exemplifies a
member of the VPS10P domain receptor gene family involved in
metabolic control [9]. The encoding gene had been associated with
type 2 diabetes in mice [4] and with type 1 and type 2 diabetes in
humans [5,6]. Subsequent studies identified SORCS1 as a sorting
receptor in pancreatic b cells, required to replenish insulin secretory
granules. Lack of SORCS1 in gene-targeted mice resulted in impaired
insulin secretion from islets when mice were made obese by leptin
ablation [10]. Interestingly, SORCS1 shares close homology with
another VPS10P domain receptor, termed SORCS3, that has been
associated with glucose levels in rats [11]. In fact, 75% identity at
the amino acid level and the adjacent localization of both receptor
genes in the mammalian genome suggests that they may be the
result of a gene duplication event [12]. In contrast to SORCS1, the
expression of SORCS3 is restricted to the central nervous system
and not seen in the pancreas [13]. Thus, the exact role of SORCS3 in
control of metabolism, and its functional interaction with SORCS1,
if any, remains unclear.
Here, we have generated novel mouse models with individual or
combined defects in Sorcs1 and Sorcs3 to shed light on a joint role of
both receptors in metabolic control. Individually, both receptor gene
defects resulted in increased adiposity in mice that was further
aggravated by dual receptor deficiency, supporting the additive
action of both receptors in energy homeostasis. Functional studies
in mouse and cell models, combined with global proteomics
approaches, documented the ability of both receptors to reduce
expression of orexigenic neuropeptides, most prominently agouti-
related peptide (AgRP), in the arcuate nucleus of the hypothalamus.
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Because surface exposure and activity of tropomyosin-related kinase
B (TrkB), the receptor for brain-derived neurotrophic factor (BDNF)
is decreased in SORCS1/3-deficient neurons, we propose that aber-
rant TrkB signaling in hypothalamic neurons causes a chronic
increase in AgRP expression, which, in turn, results in the elevated
food intake and defective nutrient partitioning seen in the mutant
mice.
Results
The genes encoding SORCS1 and SORCS3 are closely linked on mouse
chromosome 19 (Mouse Genome Informatics: 1929666). To generate
mice doubly deficient for both receptors, we made use of a murine ES
cell line heterozygous for a floxed Sorcs3 allele (Sorcs3lox/+). We had
generated this ES cell line previously to produce SORCS3-deficient
mice (referred to as S3 KO herein) [14]. Sorcs3lox/+ ES cells were
transfected with a targeting construct to delete exon 1 of the Sorcs1
locus through homologous recombination (Appendix Fig S1A). ES cell
clones carrying both targeted alleles on the same chromosome 19
(Sorcs1+/, Sorcs3lox/+) were used to generate mice doubly deficient
for Sorcs1 and Sorcs3, referred to as S1/3 KO (Appendix Fig S1B).
From the same targeting experiment, ES cell clones carrying the
targeted Sorcs1 allele but being wild type (WT) for Sorcs3 (Sorcs1+/,
Sorcs3+/+) were used to derive the single SORCS1-deficient mouse
line (S1 KO). The breeding strategy to generate all three mutant
strains is detailed in the method section. Successful gene inactivation
was confirmed by quantitative (q) RT–PCR documenting complete
absence of transcripts from the targeted Sorcs1 and Sorcs3 alleles in
brain tissue of S1/3 KO animals (Appendix Fig S1C). The availability
of antibodies directed against mouse SORCS3 enabled us to also docu-
ment absence of this receptor from brain tissue by Western blot analy-
sis (Appendix Fig S1D).
S1/3 KO mice were born at the expected Mendelian ratio and
were viable and fertile. While having normal body weight at birth,
the mutant mice weighed less at weaning and throughout adult-
hood (Fig 1A). The reduced body weight was likely due to a
decrease in lean (fat-free) mass as shown by NMR analysis of body
composition at 20 weeks of age (Fig 1B). The decrease in lean
mass was accompanied by a relative increase in fat mass (Fig 1B).
Despite the reduced body weight, S1/3 KO mice displayed an
increase in weight of subcutaneous and perigonadal white adipose
tissue (WAT) depots (Fig 1C), accompanied by WAT hypertrophy
(Fig EV1A and B). In line with increased adiposity, plasma levels
of leptin were elevated almost twofold in S1/3 KO mice compared
to WT littermates at 18 weeks of age (Fig 1D). The redistribution
between fat and lean tissues was also observed in the single S1 KO
and S3 KO lines, but was less pronounced than in double-mutant
animals, arguing for an additive effect of both gene defects on
body composition (Fig 1E). Importantly, the increased adiposity in
S1/3 KO mice was evidenced as early as 6 weeks of age
(Fig EV1C), although the WAT was not hypertrophic at this young
age (Fig EV1D).
Because of the aggravated phenotype seen in the double-mutant
as compared to the single-mutant lines (Fig 1E), we focused further
analyses on mice lacking both SORCS1 and SORCS3. Indirect gas
calorimetry was used to determine basic metabolic rates in these
animals at 21 weeks of age. Respiratory exchange ratio (RER), the
ratio of VCO2/VO2, was higher in S1/3 KO as compared to WT mice,
indicating a decrease in relative lipid consumption in mutants
(Fig 2A and B). As with WT mice, S1/3 KO animals showed diurnal
oscillations in RER, but RER values were increased in the mutants
both during the light and the dark cycle. Overall energy expenditure
adjusted for lean body mass was not affected by SORCS1/3 defi-
ciency (Fig 2C and D), but the cumulative food intake was chroni-
cally increased in S1/3 KO mice as compared to WT animals
(Fig 2E). Additionally, the spontaneous locomotor activity was
reduced (Fig 2F). The reduction in lipid consumption, as evidenced
by increased RER, was not due to an inherent defect in lipolysis in
WAT as lipolytic activity in perigonadal adipose tissue explants was
unchanged compared to WT tissue as determined by release of glyc-
erol (Fig 2G).
Given the genetic association of SORCS1 with diabetes and the
recently documented role for this receptor in insulin secretion, we
also analyzed the systemic glucose metabolism in S1/3 KO mice
fed a normal chow. Fasting plasma glucose and insulin levels
were unchanged in mutant mice (Fig EV2A). S1/3 KO mice
showed a reduced glucose tolerance when challenged with a bolus
of glucose in a glucose tolerance test (Fig EV2B and C), but
glucose-stimulated insulin secretion (Fig EV2D) and insulin sensi-
tivity (Fig EV2E) were not compromised by S1/3 gene deficien-
cies. Also, hepatic glucose production, as assessed by pyruvate
tolerance test, was normal (Fig EV2F and G). Lastly, the determi-
nation of plasma or urine levels of various hormones did not
reveal discernible changes in pituitary and adrenal activities in the
mutant mice (Table 1).
Because aging aggravates metabolic dysfunctions associated with
glucose handling and fat deposition, we explored the consequences
of SORCS1/3 deficiencies in an independent cohort of mice at 9–
10 months of age. As at younger age, aged S1/3 KO mice displayed
elevated RER (Fig 3A and B), increased cumulative food intake
(Fig 3C), and reduced locomotor activity (Fig 3D). Remarkably, the
genotype-dependent differences in RER and locomotor activity were
markedly pronounced in aged mice as compared to 21-week-old
animal with, for example, an 8% increase in RER observed at
10 months as opposed to 4% increase at 21 weeks of age. Despite
the reduction in locomotor activity in the mutants, the overall
energy expenditure adjusted for lean body mass was identical
between the genotypes at 9 months of age (Fig 3E and F).
Aging of S1/3 KO mice did not result in manifestation of hyper-
glycemia (Fig EV3A). Interestingly, although basal circulating
insulin levels were normal (Fig EV3B), glucose-stimulated increase
in plasma insulin was largely blunted in the aged mutant mice
(Fig EV3C). Insulin sensitivity was also slightly decreased in S1/3
KO animals (Fig EV3D). However, glucose tolerance was not
affected by the gene deficiency in the aged mice (Fig EV3E and F).
Taken together, ablation of SORCS1 and SORCS3 expressions in
mice on a normal chow resulted in a distinct metabolic phenotype
with a shift in energy substrate preference, diminished usage of
lipids as metabolic fuel, and increased adiposity in the absence of
classical obesity manifestation. This metabolic phenotype was obvi-
ous at 20 weeks of age and significantly aggravated with age. To
identify the tissue causing this unique metabolic phenotype, we
explored the co-expression of both receptors in brain and peripheral
tissues. The joint expression of Sorcs1 and Sorcs3 was largely con-
fined to the central nervous system (CNS) with highest transcript
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levels in cortex and hypothalamus and lower levels in hippocampus
(Fig 4A and B). With relevance to central control of metabolism,
expression of both receptors in the hypothalamus was noteworthy.
In this brain region, transcript levels were higher for Sorcs3 than for
Sorcs1 (Fig 4C). Sorcs1 transcripts showed a compensatory upregu-
lation in hypothalami lacking Sorcs3, whereas levels of Sorcs3
remained unchanged in the SORCS1-deficient hypothalamus
(Fig 4D). Using in situ hybridization, expression of Sorcs1 was
detected in the dorsomedial nucleus (DMH), the ventromedial
nucleus (VMH), and the arcuate nucleus (Arc) of the hypothalamus.
Strong Sorcs3 expression was seen in VMH and Arc (Fig 4E).
Additionally, Sorcs3 expression was detected in the paraventricular
hypothalamic nucleus (PVN; Appendix Fig S2).
Co-expression of Sorcs1 and Sorcs3 in several nuclei of the
hypothalamus suggested a defect in hypothalamic circuitry as the
underlying cause of the altered energy metabolism in S1/3 KO mice.
In support of this hypothesis, transcript levels for the appetite-stimu-
lating neuropeptide agouti-related peptide (AgRP) were increased in
mutants compared to WT mice. Increased expression of Agrp in
S1/3 KO was independent of the feeding status of the mice and seen
under fasted and fed conditions (Fig 5A). In mice fed ad libitum,
mRNA levels of another orexigenic factor, neuropeptide Y (NPY),
A
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B
Figure 1. Altered body composition and increased adiposity in mice with single or combined SORCS1 and SORCS3 deficiencies.
A Body weight of WT and S1/3 KO mice at different ages. Decreased body weight in S1/3 KO mice was observed starting from 3 weeks of age but not at post-natal day
1 (n = 7–15 animals/group).
B Body composition as determined by NMR imaging in 20- to 22-week-old mice of the indicated genotypes. S1/3 KO mice show an increase in fat mass and a
concomitant decrease in lean (fat-free) mass as compared to WT controls (n = 12–15 animals/group).
C Weight of subcutaneous (sWAT) and perigonadal (gWAT) white adipose tissue depots in WT and S1/3 KO mice at 16 weeks of age (n = 5–12 mice/group).
D Plasma leptin levels after overnight fasting in 18-week-old WT and S1/3 KO (n = 8 mice/group).
E Determination of fat and lean tissue mass in mice of the indicated genotypes using NMR. Each KO line was compared to the corresponding WT littermates. Percent
fat (or lean) mass in WT was set to 100% (n = 5–15 mice/group). Asterisks indicate results of the comparison between all four groups by one-way ANOVA (P < 0.001).
Comparisons between WT and individual KO lines were performed by Bonferroni’s post-test: P > 0.05 for S1 KO, P < 0.05 for S3 KO, P < 0.001 for S1/3 KO.
Data information: All data are shown as mean  SEM and were analyzed using a two-tailed unpaired t-test, unless otherwise stated (*P < 0.05, **P < 0.01,
***P < 0.001).
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were also elevated, accompanied by a decrease in expression of
proopiomelanocortin (POMC), the precursor of the anorexigenic
alpha-melanocyte-stimulating hormone (Fig 5A). The aberrant rise
in AgRP expression in mutants was observed as early as 8 weeks of
age and persisted in aged mice (35 weeks; Fig 5B), suggesting a
specific and chronic increase in the number and/or activity of
AgRP-producing neurons in S1/3 KO animals.
The elevation in hypothalamic AgRP production was not due to
an increase in the number of AgRP neurons as shown by crossing
S1/3 KO mice with a reporter strain expressing GFP under control of
the Npy promoter (Npy-GFP mice) [15]. Counting GFP+ cells in the
Arc of (Npy-GFP;S1/3 KO) and (Npy-GFP; WT) animals, no discern-
ible difference in cell numbers was observed comparing genotypes
(Fig 5C and D).
In previous studies, both SORCS1 and SORCS3 were implicated
in modulation of synaptic activity through trafficking of ionotropic
glutamate receptors [14,16]. Accordingly, we analyzed the conse-
quences of SORCS1/3 deficiency for the excitability of AgRP
A B
E F G
C D
Figure 2. Impaired energy homeostasis in S1/3KO mice.
WT and S1/3 KO mice were subjected to metabolic profiling by indirect calorimetry at 20–22 weeks of age (n = 8 mice/group).
A Dynamic pattern of respiratory exchange ratio (RER) in WT and S1/3 KO. Elevated RER reflects a decrease in relative lipid metabolism in S1/3 KO animals as compared
to littermate controls.
B Average RER values (from A) during the light and the dark phase (4 days and four nights average, respectively).
C 24-h energy expenditure of individual mice plotted against their lean mass.
D 24-h energy expenditure as analyzed by ANCOVA and adjusted for differences in lean body mass between the genotypes (P = 0.6378).
E Cumulative food intake in WT and S1/3 KO mice over the course of 2 days and two nights.
F Spontaneous locomotor activity of mice determined as the number of beam crossings per day and night (averaged for 4 days and four nights, respectively).
G Lipolytic activity, as determined by glycerol release from perigonadal adipose tissue explants, is not affected by loss of SORCS1/3. The glycerol concentration in the
medium was measured after 1-h incubation of tissue explants either in the absence (basal) or in the presence (IPT) of 10 lM isoproterenol (n = 8–11 mice/group).
Data information: In all panels, except for (C), data are shown as mean  SEM. Data were analyzed using two-way ANOVA with Bonferroni post-test (A, B, E–G) or
ANCOVA (C, D). *P < 0.05.
Table 1. Levels of circulating hormones and metabolites in overnight fasted WT and S1/3 KO mice
Hormone Sample WT S1/3 KO P value
Growth hormone (pg/ml) Plasma 153.4  15.2 179.5  21.0 0.3326
Adrenocorticotropic hormone (pg/ml) Plasma 251.0  14.1 205.9  24.3 0.1847
Corticosterone (ng/ml) Plasma 131.0  24.3 170.5  34.4 0.3460
Epinephrine (lg/g creatinine) Urine 90.1  9.1 108.0  9.0 0.1785
Norepinephrine (lg/g creatinine) Urine 500.5  33.8 541.1  25.0 0.3392
Data are shown as mean  SEM and were analyzed using a two-tailed unpaired t-test (n = 5–15 mice/group).
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Figure 3. Impaired energy homeostasis in aged S1/3KO mice.
WT and S1/3 KO mice were subjected to metabolic profiling by indirect calorimetry at 9–10 months of age (n = 7–8 mice/group).
A Dynamic pattern of respiratory exchange ratio (RER) in WT and S1/3 KO.
B RER values (from A) during the light and the dark phase (3 days and three nights average, respectively).
C Cumulative food intake in WT and S1/3 KO mice over the course of 2 days and two nights.
D Spontaneous locomotor activity of mice determined as the number of beam crossings per day and per night (averaged for 3 days and three nights, respectively).
E 24-h energy expenditure of individual mice plotted against their lean mass.
F 24-h energy expenditure as analyzed by ANCOVA and adjusted for differences in lean body mass between the genotypes (P = 0.9045).
Data information: In all panels, except for (E), data are shown as mean  SEM. Data were analyzed using two-way ANOVA with Bonferroni post-test (A–D) or ANCOVA
(E, F). ****P < 0.0001.
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neurons. To do so, membrane potentials and firing rates of AgRP
neurons were recorded in acute brain slices from fed Npy-GFP mice.
No genotype-specific difference was observed in firing rates of AgRP
neurons (Appendix Fig S3A), although AgRP neurons from S1/3 KO
mice were slightly depolarized (Appendix Fig S3B).
To identify the cause for the upregulation of Agrp transcription
in mutant mice, we assessed the levels of Kru¨ppel-like factor
(KLF4), a transcription factor that potently induces Agrp gene tran-
scription in vitro and in vivo [17–19]. In line with aberrant induction
of Agrp transcription under fed conditions, levels of KLF4 in the Arc
were significantly increased in S1/3 KO mice as documented by
quantitative immunohistochemistry (Fig 5E and F).
AgRP is one of the mediators of AgRP/NPY neuronal action in
metabolic control. It acts as an inverse agonist of melanocortin-3
and melanocortin-4 receptors (MC3R, MC4R) to stimulate feeding
and to decrease energy expenditure in a long-lasting manner
[20–22]. Both Agrp expression and AgRP/NPY neuronal activity are
inhibited by leptin, in part mediating leptin’s anorexigenic effects
[23,24]. In line with the chronically increased AgRP levels, leptin
injection caused a lesser reduction of food intake in S1/3 KO mice
compared to WT controls (Fig 6A). As another indication of
elevated AgRP levels and downregulated melanocortin receptor
signaling, the cold tolerance of mutant mice was attenuated, as
judged by a stronger decrease in body core temperature in response
to short-term cold exposure compared to WT littermates (Fig 6B). In
line with the latter defect, the relative expression of thermogenic
genes was decreased in the WAT of cold-exposed S1/3 KO mice
compared to controls (Fig 6C).
Multiple mechanisms may be envisioned how sorting receptors
SORCS1 and SORCS3 may, directly or indirectly, control AgRP
expression in hypothalamic neurons. To explore the underlying
molecular concept, we turned to an unbiased proteomics approach
comparing the surface proteome of WT and S1/3 KO primary
neurons. We reasoned that combined absence of these sorting
receptors should result in aberrant distribution of yet unknown
cargo between cell surface and intracellular compartments. To iden-
tify such targets, surface proteins in primary cortical neurons from
WT and S1/S3 KO animals were biotinylated. Subsequently,
A B E
C D
Figure 4. Co-expression of Sorcs1 and Sorcs3 in the hypothalamus.
A, B Transcript levels for Sorcs1 (A) and Sorcs3 (B) in the indicated mouse tissues were assessed by quantitative (q) RT–PCR. Expression levels in the hippocampus were
set to 1 (n = 3 mice/group, 10 weeks of age).
C Comparison of Sorcs1 and Sorcs3 transcript levels using qRT–PCR in hypothalami of WT mice. Identical amplification efficiency for both gene expression assays was
validated in a separate experiment (n = 5 mice/group).
D Transcript levels for Sorcs1 and Sorcs3 as assessed by qRT–PCR in hypothalami from mice with single Sorcs1 (S1 KO) or Sorcs3 (S3 KO) deficiencies. S3 KO mice show
a compensatory increase in Sorcs1 expression compared to WT controls. Expression in WT was set to 1 (n = 5–10 mice/group).
E In situ hybridization (ISH) for Sorcs1 and Sorcs3 on coronal brain sections indicating expression of both receptors in cerebral cortex and in various nuclei of the
hypothalamus (Arc: arcuate nucleus; VMH: ventromedial nucleus; DMH: dorsomedial nucleus). ISH for Agrp and Npy on adjacent sections was used as controls for
identification of the arcuate nucleus. For each gene, the lower panel represents a higher magnification of the hypothalamus area (marked in the overview
micrograph of ISH for Sorcs1). Scale bar: 500 lm; n = 3 mice.
Data information: Data in (A–D) are shown as mean  SD and were analyzed using a two-tailed unpaired t-test. **P < 0.01, ***P < 0.001.
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Figure 5. Loss of SORCS1 and SORCS3 increases hypothalamic expression of Agrp and Klf4.
A Expression of hypothalamic neuropeptides and hormones as assessed by quantitative (q)RT–PCR in overnight fasted and ad libitum fed mice at 21 weeks of age.
Log2-fold change expression in S1/3 KO relative to the expression in WT is shown. Agrp transcript levels are increased in S1/3 KO under both fasted and fed
conditions. n = 8–11 (fasted) or 4–5 (fed) mice/group. Agrp, agouti-related peptide; Npy, neuropeptide Y; Pomc, proopiomelanocortin; Crh, corticotropin-releasing
hormone; Trh, thyrotropin-releasing hormone.
B Expression of hypothalamic neuropeptides and hormones as assessed by quantitative (q) RT–PCR in overnight fasted mice at 8 or 35 weeks of age. Log2-fold change
expression in S1/3 KO relative to the expression in WT is shown. n = 4–6 (8-week-old) or 14–16 (35-week-old) mice/group.
C Detection of NPY/AgRP neurons by native fluorescence of GFP (green) in the arcuate nucleus of Npy-hrGFP mice either wild type (Npy-GFP/WT) or homozygous
deficient for SORCS1/3 (Npy-GFP/S1/3 KO) at 10 weeks of age. Mice were fed ad libitum. Scale bar: 100 lm; 3V, third ventricle.
D The total number of NPY/AgRP neurons, as identified by GFP fluorescence, is not affected by loss of SORCS1/3. Six histological sections across the arcuate nucleus per
Npy-GFP/WT or Npy-GFP/S1/3 KO mouse (as exemplified in panel C) were scored (n = 3 mice/group).
E Immunodetection of KLF4 (red) in the arcuate nucleus of Npy-GFP/WT and Npy-GFP/S1/3 KO mice. NPY/AgRP neurons were identified by GFP fluorescence (green).
Mice were fed ad libitum (n = 6 mice/group). Scale bar: 100 lm; 3V, third ventricle.
F Quantification of the KLF4-positive area in NPY/AgRP neurons on histological sections as exemplified in (E). Two sections per mouse in the middle part of the arcuate
nucleus (the region 1.82–1.94 mm caudal to bregma) were analyzed. n = 3 (fasted) or 6 (fed) mice/group.
Data information: Data are shown as mean  SEM and were analyzed using a two-tailed unpaired t-test (A, B, D) or two-way ANOVA with Bonferroni post-test (F).
*P < 0.05, **P < 0.01.
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biotinylated proteins were purified from cell extracts using strepta-
vidin beads and subjected to quantitative label-free proteomics
using LC-MS/MS (Fig 7A). Several proteins with altered cell surface
exposure in S1/3 KO as compared to control neurons were identi-
fied, including receptors, transporters as well as proteins involved
in vesicle trafficking and neurotransmitter release (Fig 7B,
Table EV1). Proteins with altered surface exposure in S1/3 KO
neurons included the established SORCS1 ligands amyloid precursor
protein [25] and neurexin [16], providing proof for the feasibility of
our approach to identify novel receptor targets (Table EV1). One
candidate with particular relevance to VPS10P domain receptor biol-
ogy and to metabolic control, that caught our attention, was TrkB,
encoded by Ntrk2. Surface exposure of TrkB was increased 1.57-fold
in S1/3 KO neurons as compared to controls (P = 0.02; Table EV1).
TrkB acts as high-affinity receptor for BDNF, a regulator of neuronal
survival, differentiation, and synaptic plasticity (reviewed in ref.
[26]). With relevance to this study, perturbations of the BDNF
signaling pathway also result in metabolic imbalance in mice and
humans, but the mechanisms whereby this neurotrophin affects
satiety and energy expenditure are still not fully understood (re-
viewed in refs. [27,28]).
Altered subcellular localization of TrkB in neurons from S1/3 KO
mice was further substantiated in vivo by subjecting mouse brains
to membrane fractionation (Fig 7C) and subsequent Western blot
analysis (Fig 7D). The accuracy of the membrane fractionation was
confirmed by the enrichment of protein markers (PSD95, synapto-
physin, Golgin 97) for various membrane compartments in these
fractions (Fig 7D). Quantitative analysis of replicate experiments
showed that loss of SORCS1 and SORCS3 resulted in the redistribu-
tion of TrkB between the light membrane-enriched (P3) and synap-
tosomal membrane (P2) fractions (Fig 7E). Whereas TrkB levels
were equally distributed between P3- and P2-fractions in WT brains,
the receptor pool was shifted from synaptosomal- toward light
membrane-enriched fraction in S1/3 KO brains, suggesting accumu-
lation of TrkB in sorting vesicles.
Intriguingly, VPS10P domain receptors sortilin [29], SORLA [30],
and SORCS2 [31] have been shown to interact with TrkB and to
facilitate functional expression of this receptor. Sortilin and SORLA
facilitate trafficking of TrkB in neurites of dorsal root ganglion and
hippocampal neurons, respectively. SORCS2 targets TrkB to the
post-synaptic density of hippocampal neurons. Using co-immuno-
precipitation from transiently transfected Chinese hamster ovary
cells, we now document the ability of SORCS1 and SORCS3 to also
bind TrkB (Fig 7F and G).
At the molecular level, BDNF binding causes dimerization and
transphosphorylation of TrkB, triggering activation of several signal-
ing pathways, ultimately leading to the induction of BDNF target
gene transcription. When treated with exogenously added BDNF,
S1/3 KO cortical neurons showed an acutely increased response in
terms of TrkB phosphorylation (Fig 8A and B). This observation
suggested an inhibitory action of SORCS1 and SORCS3 on TrkB that
contrasts the stimulatory activity seen for all other VPS10P domain
receptors. This inhibitory action of SORCS1 and SORCS3 was also
apparent in acute hypothalamic slices with elevated levels of phos-
phorylated (p) TrkB seen in S1/3 KO as compared to WT tissues
following BDNF stimulation (Fig 8C and D).
To verify that the documented interaction of SORCS1 and SORCS3
with TrkB can occur in AgRP neurons, we tested expression of both
receptors and TrkB in this neuronal population. To do so, we
performed fluorescence-activated cell sorting (FACS) on dissociated
arcuate nuclei from adult Npy-GFP mice (Fig 8E). In sorted GFP+-
neurons, Agrp transcripts were strongly enriched, whereas transcripts
for growth hormone-releasing hormone (Ghrh), which is not
expressed by AgRP neurons [32], were undetected, indicating specific
isolation of the AgRP neuronal transcriptome in our assay. Expression
of both Sorcs1 and Sorcs3 was detected in AgRP neurons, with Sorcs3
transcripts being 2.5-fold enriched in this neuronal population as
A
C
B
Figure 6. Pathophysiological effects of dysregulated melanocortin
system in S1/3KO mice.
A The effect of peripheral leptin (2.5 mg/kg body weight) or vehicle
(phosphate-buffered saline, PBS) administration on food intake in 15-week-
old mice measured over a 24-h period (n = 8 mice/group). The leptin
sensitivity was reduced in S1/3 KO mice.
B Rectal temperature in 16-week-old mice of the indicated genotypes kept at
room temperature and after 6 h of cold exposure (4°C) (n = 7–8
mice/group). Cold-induced thermogenesis is impaired in S1/3 KO mice (two-
way ANOVA, pgenotype = 0.0435).
C Expression of thermogenic genes in perigonadal adipose tissue from mice
after 6-to 16-h cold exposure (4°C). Quantitative RT–PCR data are shown as
log2-fold change expression in S1/3 KO relative to the expression in WT
(n = 13–14 mice/group). Cold-induced browning of white adipose tissue is
impaired in S1/3 KO as judged by decreased expression of the indicated
genes. Ucp1, uncoupling protein 1; Cidea, cell death activator CIDE-A;
Pppargc1a, peroxisome proliferator-activated receptor c co-activator 1-a;
Adrb3, b-3 adrenergic receptor; Pnpla2, adipose triglyceride lipase; Lipe,
hormone-sensitive lipase.
Data information: Data are shown as mean  SEM and analyzed using a two-
tailed unpaired t-test (C) or two-way ANOVA with Bonferroni post-test (A, B).
*P < 0.05.
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compared to the transcriptome of the unsorted arcuate nucleus.
Expression of Ntrk2 (TrkB) was also clearly detected in AgRP neurons
(Fig 8E), in line with findings from single-cell transcriptomics studies
performed on dissociated AgRP neurons by others [33].
Next, we asked whether BDNF could affect Agrp expression
through the action of KLF4 in hypothalamic neurons. Treatment of
primary hypothalamic neurons with BDNF for 48 h caused a strong
induction in Agrp expression (Fig 8F). Along with Agrp, expression
of Npy and somatostatin (Sst) was also increased in BDNF-treated
hypothalamic neurons. The two latter genes were reported to be
responsive to BDNF in cultured cortical neurons and in various
brain areas in vivo [34–37]. In contrast, transcript levels of Ghrh
were not affected by the neurotrophin treatment, documenting that
upregulation of Agrp and Npy expression was not due to a general
augmentation of neuronal viability by BDNF. Though the exact
pathway for BDNF-dependent induction of Agrp transcription is
unclear yet, KLF4 is a plausible candidate for mediating this effect
as it is a target of neurotrophin signaling in established cell lines
and primary hippocampal neurons [38–40]. In line with this notion,
Klf4 expression was rapidly upregulated by BDNF in the primary
hypothalamic neurons in our experiments (Fig 8G).
Based on the altered subcellular localization of TrkB in the mutant
brain (Fig 7D and E), SORCS1 and SORCS3 may regulate axonal and/
or dendritic transport of TrkB-containing vesicles in neurons, thereby
affecting surface exposure of the receptor and its availability to BDNF.
To substantiate this model, we analyzed trafficking of a green fluores-
cent protein (GFP)-tagged TrkB in live primary cortical neurons from
WT and S1/3 KO mice. Analysis of kymographs visualizing axonal
transport of GFP-TrkB did not reveal any significant difference in the
kinetics parameters of TrkB-containing vesicles comparing WT and
S1/3 KO neurons (Fig EV4). However, the distribution of retrogradely
(from neurite toward cell body) and anterogradely (from cell body
toward neurite) moving cargo vesicles tended to be affected by the
genotype, with possibly decreased retrograde and increased antero-
grade pools in S1/3 KO neurons (Fig EV4C). In line with this observa-
tion, the total distance (run length) covered by TrkB vesicles within
an uninterrupted period of retrograde movement showed a tendency
to being decreased in S1/3 KO neurons (Fig EV4D).
Our data are consistent with a model whereby SORCS1 and
SORCS3 functionally interact with TrkB to alter its subcellular
localization and downregulate signaling by BDNF in hypothalamic
neurons. Absence of these sorting receptors increases the bioactive
TrkB pool at the neuronal cell surface and coincides with chronic
transcriptional induction of Agrp through the BDNF target KLF4,
ultimately impairing energy homeostasis in S1/3 KO mice.
Discussion
We applied novel mouse models with individual or combined
deficiencies for SORCS1 and SORCS3 to explore roles for these
related receptors in control of metabolism. Combined loss of
SORCS1 and SORCS3 causes a unique metabolic phenotype that
impacts body composition with accumulation of fat over lean tissue
mass. Altered body composition is accompanied by a shift in meta-
bolic fuel preference with preferred usage of carbohydrates over
lipids. In addition to defective nutrient partitioning, S1/3 KO mice
display increased cumulative food intake and decreased locomotor
activity, resulting in a state of chronic energy excess. This positive
energy balance likely explains the increased adiposity seen in mice
with individual and, in aggravated form, in animals with combined
receptor gene defects.
No major alterations in glucose homeostasis were detected in S1/
3 KO mice on a normal chow. Though the mutant mice showed a
mild impairment in glucose tolerance at young age (12 weeks;
Fig EV2B and C), this phenotype did not progress to hyperglycemia
during aging (Fig EV3A), suggesting that SORCS1 and SORCS3 are
dispensable for glycemic control in chow-fed mice. Aged S1/3 KO
animals exhibit a reduction in insulin sensitivity as well as
decreased insulin levels after a bolus of glucose (Fig EV3C and D),
consistent with the phenotype documented for mice singly deficient
for SORCS1 [10]. Importantly, SORCS1-deficient mice developed
these defects exclusively when made genetically obese by introduc-
tion of the leptinob mutation, while our model displayed blunted
insulin secretion with advanced age only. Jointly, these findings
support the notion that type 2 diabetes associated Sorcs1 plays a role
in complex gene–environment interactions in this disease. Defects
in glucose handling in obese Sorcs1 mutants were attributed to the
loss of SORCS1 from pancreatic islets, where SORCS3 is not
expressed [4]. Our finding that combined ablation of SORCS1 and
▸Figure 7. Altered subcellular localization of TrkB in primary neurons and brains from S1/3 KO mice.A Workflow of the cell surface proteome analysis in primary neurons.
B Results of quantitative label-free proteomics comparing the surface proteomes of WT and S1/3 KO primary cortical neurons. Plot represents –log10(P-value) and
log2 (relative levels S1/3KO/WT) obtained for each protein. For proteins that were detected in either S1/3 KO or WT samples only, the log2(S1/3 KO/WT) was set to
10 or -10, respectively. Threshold values are 1.3 for –log10(P-value) and 0.3 for log2(S1/3 KO/WT). Proteins showing higher (green) or lower (red) surface levels in
S1/3 KO as compared to WT neurons are indicated. Proteins with unchanged cell surface levels are indicated in blue. n = 3 biological replicates/group (with each
biological replicate run in two technical replicates).
C Scheme of brain membrane fractionation used to analyze subcellular localization of TrkB in vivo (see method section for details).
D Representative Western blotting of TrkB in various brain membrane fractions obtained as described in panel (C). Highlighted lanes represent P3 and P2 fractions,
quantified in (E). Detection of PSD95, synaptophysin, and Golgin 97 was used to assess the accuracy of subcellular fractionation.
E Quantification of total TrkB distribution between P3 (light membrane fraction) and P2 (synaptosomal fraction) from Western blots exemplified in panel (D) (n = 5
mice/group, 7–12 weeks of age). The TrkB pool is shifted toward the light membrane (P3) fraction in S1/3 KO brains. Data are shown as mean  SEM and analyzed
using two-way ANOVA with Bonferroni post-test. ****P < 0.0001.
F, G Co-immunoprecipitation of SORCS1 and SORCS3 with TrkB. TrkB was immunoprecipitated from transiently transfected Chinese hamster ovary cells and the
presence of SORCS1 or SORCS3 in the immunoprecipitates documented by Western blotting. Panel input shows levels of the indicated proteins in the cell lysates
prior to immunoprecipitation. Panel IP documents co-immunoprecipitation of SORCS1 (F) and SORCS3 (G) from cells expressing (lanes 3) but not from cells lacking
TrkB (lanes 2). The experiment was replicated twice.
Source data are available online for this figure.
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SORCS3 impairs insulin secretion in lean mice, argues that centrally
expressed SORCS3 contributes to the regulation of insulin levels. In
this respect, expression of SORCS3 in the hypothalamus is of partic-
ular interest, since hypothalamic neurons sense glucose and control
secretion of pancreatic hormones [41].
The hypothalamus is also one of the key brain areas in control of
food intake and nutrient partitioning. Ablation of SORCS1 and
SORCS3 results in the increased expression of AgRP (Fig 5A and B),
an orexigenic neuropeptide expressed mainly by Arc neurons. Gain
of AgRP function achieved experimentally by injection or over-
expression of the peptide evokes phenotypes that are seen chronically
in S1/3 KO mice, including elevated food intake, increased RER,
decreased locomotor activity, reduced body temperature, and
adipose tissue accumulation and hypertrophy [22,42–44]. Sorcs1
and Sorcs3 are expressed in AgRP neurons (Fig 8E), with Sorcs1
expression being profoundly regulated by fasting [33]. These data
A B
C
E F G
D
Figure 7.
EMBO reports e44810 | 2018 ª 2018 The Authors
EMBO reports SORCS1 and SORCS3 in central control of metabolism Aygul Subkhangulova et al
10 of 18
Published online: February 12, 2018 
AB
E
F G
C
D
Figure 8. Deficiency for SORCS1 and SORCS3 enhances BDNF signaling in primary cortical neurons and acute hypothalamic slices.
A Representative Western blots showing phosphorylated TrkB (pTrk) and total TrkB levels in DIV7 primary cortical neurons treated with BDNF (100 ng/ml) for the
indicated periods of time. Detection of tubulin served as loading control.
B Quantification by densitometric scanning of replicate blots (n = 4 biological replicates/genotype), as exemplified in panel (A), documents an increase in pTrkB levels in
S1/3 KO neurons compared to WT neurons 10 min after BNDF application.
C Representative Western blots showing phosphorylated TrkB (pTrk) and total TrkB levels in acute hypothalamic slices of the indicated genotypes treated with BDNF
(200 ng/ml) for 1 h. Detection of GAPDH served as a loading control.
D Quantification by densitometric scanning of replicate blots (n = 14–15 mice/genotype), as exemplified in panel (C), documents an increase in pTrkB levels in S1/3 KO
compared to WT hypothalamic slices.
E Expression of the indicated genes as analyzed by qRT–PCR in FACS-sorted NPY/AgRP neurons (GFP+) from fasted Npy-GFP mice. Expression in the sorted neurons was
related to the expression in the whole (dissociated, but not FACS-sorted) arcuate nucleus (Arc). Tissue from 10 mice was pooled for the experiment.
F Expression of neuropeptides as analyzed by qRT–PCR in DIV8 primary hypothalamic neurons treated with BDNF (100 ng/ml) for 48 h. The log2-fold change in
expression relative to the expression levels in vehicle-treated neurons is shown. n = 5–6 technical replicates/treatment; data are from two neuronal culture
preparations; 8-9 hypothalami pooled in a single preparation.
G Expression of immediate early genes and neuropeptides as analyzed by qRT–PCR in DIV8 primary hypothalamic neurons treated with BDNF (100 ng/ml) for 1.5 h. The
log2-fold change in expression relative to the expression level in vehicle-treated neurons is shown. n = 4 technical replicates/treatment; data are from two neuronal
culture preparations; 8-9 hypothalami pooled in a single preparation.
Data information: Data in (B, D, F, and G) are shown as mean  SEM and analyzed using two-way ANOVA with Bonferroni post-test (B) or a two-tailed unpaired t-test
(D, F, G). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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argue for a cell-autonomous function of the two receptors in regula-
tion of AgRP expression.
The chronic increase in AgRP expression was documented in S1/3
KO mice as early as at 8 weeks of age and was preserved in aged mice
(10 months). By magnitude, this increase is comparable to the change
in Agrp transcription (50%) observed in rodents upon prolonged fast-
ing [45–47]. The increase in Agrp expression in S1/3 KO mice was
independent not only of age, but also of feeding status. This observa-
tion strongly suggests that the effect of SORCS1/3 ablation on Agrp
transcription is not simply a consequence of developing leptin resis-
tance, since leptin levels are greatly affected by fasting and age [48].
Rather, the attenuated capacity of leptin to decrease food intake in S1/
3 KO mice, as seen at 15 weeks of age (Fig 6A), can be explained by
the chronically increased AgRP levels in these animals. Importantly,
enhanced expression of AgRP in S1/3 KO mice is already seen at the
onset of adulthood (8 weeks), which likely precedes any age- and
adiposity-related decline in leptin sensitivity [49].
Interestingly, the phenotype of S1/3 KO mice bears close resem-
blance to that of MC3R-deficient animals [50,51]. AgRP acts as an
inverse agonist of melanocortin receptors MC3R and MC4R, block-
ing their activity on the second-order neurons throughout the CNS
[22,52]. While lack of MC4R leads to overt obesity with a simultane-
ous rise in fat and lean tissue mass [53], deficiency in MC3R (as well
as in SORCS1/3) results in an increased fat and a concomitantly
decreased lean mass, and in aberrant nutrient partitioning in the
absence of classical obesity [50,51]. These similarities place SORCS1
and SORCS3 as modulators of the melanocortin system that act in a
subset of AgRP/NPY neurons projecting to brain areas with the
predominant MC3R expression.
We identified an increased responsiveness to BDNF as a plausi-
ble cause of aberrant neuropeptide expression in S1/3 KO neurons.
Among its many functions, BDNF emerges as an important regulator
of energy expenditure [27,28]. With relevance to this study, BDNF
modulates expression and secretion of various neuropeptides (e.g.,
oxytocin, NPY, somatostatin) in cultured hypothalamic and cortical
neurons as well as in vivo [34–37,54]. Now, we show robust upreg-
ulation of Agrp transcription in primary hypothalamic neurons
treated with BDNF, documenting AgRP as a novel target of BDNF
signaling (Fig 8F). In agreement with our finding, virus-mediated
overexpression of BDNF in the hypothalamus leads to a 15-fold
increase in Agrp mRNA levels in mice [55]. We also show expres-
sion of the BDNF receptor TrkB in FACS-sorted NPY/AgRP neurons
(Fig 8E), arguing that the effect of BDNF on this neuronal popula-
tion is, at least in part, cell autonomous. In support of our conclu-
sion, TrkB transcripts were detected at relatively high levels in
NPY/AgRP neurons by high-throughput transcriptomics and found
to increase by 40% with fasting [33].
Primary cortical neurons and hypothalamic slices from S1/3 KO
mice show increased sensitivity to exogenously applied BDNF, as
evidenced by the enhanced TrkB phosphorylation (Fig 8A–D).
Increased responsiveness to BDNF may be explained by the altered
subcellular localization of TrkB in primary neurons and in brains
lacking SORCS1 and SORCS3 (Fig 7). Given that both SORCS1 and
SORCS3 bind TrkB, we proposed a role for the two receptors in
intracellular trafficking of TrkB. Our model is in agreement with the
function of other VPS10P domain receptors that control neuronal
sorting of various neurotrophin receptors [29–31]. In contrast to
other VPS10P domain receptors, that typically promote
neurotrophin signals, SORCS1 and SORCS3 appear distinct as they
attenuate BDNF signaling, presumably by reducing the active pool
of TrkB on the surface of neuronal processes. Our data do not
exclude that aberrant BDNF signaling in hypothalamic cell popula-
tions other than NPY/AgRP neurons, or in higher brain structures,
may contribute to the phenotype of S1/3 KO mice. However, consid-
ering the prominent hypothalamic expression pattern of SORCS1
and SORCS3, and the chronic increase in AgRP levels in S1/3 KO
mice, loss of the two sorting receptors from NPY/AgRP neurons
appears to be a primary contributor to the increased feeding behav-
ior and worsened nutrient partitioning in these animals.
How does BDNF/TrkB signaling affect Agrp transcription? A
plausible mediator of this action is KLF4. Its expression is rapidly
induced by BDNF in established cell lines and primary hippocampal
neurons [38–40], as well as in primary hypothalamic neurons in this
study (Fig 8G). KLF4 is produced in NPY/AgRP neurons and
directly activates Agrp transcription [17,18]. Increased levels of
KLF4 in the Arc of S1/3 KO mice coincide with upregulated AgRP
expression and can be explained by enhanced hypothalamic BDNF
signaling in the absence of SORCS1/3. Despite having documented a
genotype-specific difference in vivo, we failed to recapitulate robust
differences in the induction of Klf4 and Agrp transcription by BDNF
comparing primary hypothalamic S1/3 KO and WT neurons (data
not shown). In vivo, BDNF is released locally and in limited
amounts, making axonal/dendritic localization of TrkB crucial for
control of signal perception. Possibly, stimulation of cultured post-
natal neurons with an excess of BDNF obscures the modulatory
effects of SORCS1 and SORCS3 activities on TrkB trafficking and
signal transmission in vitro.
Given the stimulatory role of BDNF on orexigenic neuropeptide
expression (Fig 8F), the well-established anorexigenic effects of
acute BDNF delivery in rodents seem contradictory. For example,
hypothalamic overexpression of BDNF or acute delivery to PVH or
VMH causes a strong decrease in food intake and loss of body
weight, whereas chronic reduction of TrkB or BDNF levels in TrkB-
and BDNF-heterozygous mice increases body weight and adiposity
[56–58]. Conceivably, BDNF action in specific neuronal populations
may have different, if not opposing effects on energy metabolism.
Supporting this notion, the modulation of the BDNF pathway by
TrkB agonists in vivo resulted in reduced, unchanged, or even
increased food intake in rodents, depending on the pharmacological
agent and the route of its administration [59,60]. Also, peripheral
administration of BDNF in non-human primates led to a gain in
appetite and increased adiposity [61]. In the end, seemingly contra-
dictory systemic effects of manipulating the BDNF/TrkB pathway
may largely depend on the distinct experimental conditions eliciting
different effects in specific neuronal populations.
In conclusion, our findings identified a novel role for VPS10P
domain receptors SORCS1 and SORCS3 in hypothalamic control of
metabolism through regulation of orexigenic peptide production.
Clearly, different scenarios may be envisioned whereby these multi-
functional receptors impact energy homeostasis. Our data suggest a
model in which SORCS1 and SORCS3 functionally interact with
TrkB to alter its subcellular localization and, thereby, reduce
responsiveness of this receptor to BDNF signals in hypothalamic
neurons. Obviously, further studies will be required to ultimately
resolve the molecular mechanism(s) underlying the action of these
sorting receptors in regulation of energy balance.
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Materials and Methods
Mouse models
Mice with targeted disruption of Sorcs3 (S3 KO) have been
described before [14]. To produce mice with combined deficiencies
for Sorcs3 and Sorcs1 (S1/3 KO), murine embryonic stem (ES) cells
heterozygous for the floxed Sorcs3 allele (Sorcs3lox/+) were trans-
fected with a targeting construct in which exon 1 of Sorcs1 was
replaced by a puromycin expression cassette flanked by FRT sites
(Appendix Fig S1A). Positive ES cell clones were injected into blas-
tocysts to generate germ-line chimera carrying the targeted Sorcs1
and Sorcs3 alleles on the same chromosome 19. Subsequently, the
mice were crossed with the Cre deleter strain (B6.C-TgCMV-cre1Cgn/
J; Jackson Laboratories) to remove the floxed exon 1 from the
targeted Sorcs3 locus and with Flp deleter animals (B6.129S4-Gt
(ROSA)26Sortm1(FLP1)Dym/RainJ; Jackson Laboratories) to remove the
puromycin cassette in Sorcs1. The resulting (Sorcs1+/, Sorcs3+/)
mice were backcrossed to C57Bl/6N wild-type animals for seven
generations. To generate the single Sorcs1-targeted line (S1 KO), ES
cell clones carrying the targeted Sorcs1 allele on the Sorcs3+/+
background were selected from the same ES cell targeting experi-
ment and used to generate germ-line chimeras. All single or doubly
targeted mouse strains were kept by breeding of heterozygous
animals on an inbred C57Bl/6N genetic background (Appendix Fig
S1B).
S1/3 KO mice expressing humanized renilla (hr)GFP in AgRP/
NPY neurons were generated by crossing Sorcs1/3/ and Npy-GFP
mice (6.FVB-Tg(Npy-hrGFP)1Lowl/J; stock number 006417; The
Jackson Laboratory). The resulting Sorcs1/3+/ mice carrying
one copy of the NPY-GFP transgene (Npy-GFPTg/) were bred with
(Sorcs1/3+/) animals to derive (Sorcs1/3/; Npy-GFPTg/) (Npy/S1/
3 KO) and littermate controls (Sorcs1/3+/+; Npy-GFPTg/) (Npy/WT)
for analysis.
Mice were kept under stable environmental conditions on a 12/
12-h light/dark cycle and fed a standard chow diet providing 66
kcal% from carbohydrates, 23 kcal% from protein, and 11 kcal%
from fat (Sniff Spezialdia¨ten GmbH). Analyses were performed in
female mice comparing mutant animals with their matched litter-
mate controls. Age of the mice used in various experiments is speci-
fied in the respective figure legends. All animal experimentation
was performed in accordance with institutional guidelines following
approval by the local authorities of the State of Berlin (X9012/12,
G0339/12).
Metabolic phenotyping of mice
Body composition was assessed in conscious mice by nuclear
magnetic resonance imaging. Food intake, gas exchange, and spon-
taneous locomotor activity were recorded in metabolic cages (TSE
PhenoMaster System, TSE Systems). In detail, animals were kept in
metabolic cages individually for four consecutive days, with the first
day being considered as adaptation period (not analyzed). Parame-
ters for each mouse were recorded at 8-min intervals. Data were
analyzed according to the guidelines provided in [62]. Energy
expenditure was determined by indirect gas calorimetry and
adjusted for lean body mass by analysis of covariance (ANCOVA).
Respiratory exchange ratio was calculated as the ratio between
volumes of CO2 produced and O2 consumed. Spontaneous locomo-
tor activity was measured by recording interruptions of infrared
light beams emitted along the x- and y-axis of each cage. Analysis of
glucose metabolism of mice is detailed in Appendix Supplementary
Methods.
Measurement of hormones
For measurement of blood hormones, mice were fasted overnight
and blood was collected from the facial vein of non-anesthetized
animals (for insulin and corticosterone), or by cardiac puncture
from terminally anesthetized animals (for adrenocorticotropic
hormone (ACTH) and growth hormone, leptin) in EDTA-treated
tubes. Urine samples were collected overnight in metabolic cages.
All hormones, except for ACTH, were measured using commercially
available ELISA (Crystal Chem Inc. #90080; Enzo Life Sciences, Inc.
ADI-900-097; Cloud-Clone Corp. SEA044Mu; Crystal Chem #90030).
Plasma ACTH and urinary catecholamines were measured by diag-
nostic laboratory Biocontrol.
Leptin sensitivity test
To measure effect of leptin on food intake, 14–16-week-old mice
were i. p. injected with vehicle (PBS) on the first day of experiment
(9 am and 6 pm) and with recombinant mouse leptin (2.5 mg/kg
body weight; Sigma L3772) on the second day (9 am and 6 pm).
Food intake was measured over a 24-h period after the first vehicle
or leptin injection.
Lipolytic activity in adipose tissue explants
Lipolytic activity of perigonadal adipose tissue was assessed in vitro
essentially as described [63]. In brief, perigonadal adipose tissue
pads were dissected from overnight fasted 22-week-old mice, cut
into pieces (~70 mg), washed in PBS, and incubated for 1 h at 37°C
in DMEM with 2% fatty acid-free bovine serum albumin. Thereafter,
tissue explants were moved to the fresh medium with or without
10 lM isoproterenol for 1 h. Medium from the explants was
analyzed for glycerol using a commercially available kit (Biovision
#K630-100). Glycerol released in the medium was normalized to
tissue protein content. Protein extraction from tissue explants was
performed as described [64].
Quantitative RT–PCR
Total RNA was extracted from tissue and cell lysates using TRIzol
reagent and purified with RNeasy Mini/Micro Kit (Qiagen). Reversely
transcribed cDNA from total RNA was subjected to qRT–PCR using
the following Taqman Gene Expression Assays: Sorcs1 ex 23 and 24
(Mm00491259_m1), Sorcs3 ex 5 and 6 (Mm00458702_m1), Agrp
(Mm00475829_g1), Npy (Mm01410146_m1), Pomc (Mm00
435874_m1), Crh (Mm01293920_s1), Trh (Mm01182425_g1), Klf4
(Mm00516104_m1), Ucp1 (Mm01244861_m1), Cidea (Mm004325
54_m1), Ppargc1a (Mm01208835_m1), Adrb3 (Mm02601819_g1),
Pnpla2 (Mm00503040_m1), Lipe (Mm00495359_m1), Sst (Mm00
436671_m1), Ghrh (Mm00439100_m1), c-fos (Mm00487425_m1),
Actb (Mm02619580_g1), Gapdh (Mm99999915_g1). Fold change in
gene expression was calculated using the cycle threshold (CT)
ª 2018 The Authors EMBO reports e44810 | 2018
Aygul Subkhangulova et al SORCS1 and SORCS3 in central control of metabolism EMBO reports
13 of 18
Published online: February 12, 2018 
comparative method (2ddCT) normalizing to Gapdh or Actb CT values
[65].
Histology and immunodetection
Perigonadal adipose tissue pads and quadriceps muscle were
dissected from 14- to 15-week-old mice, fixed in 4% paraformalde-
hyde (PFA), and embedded in paraffin. Tissue sections were stained
with hematoxylin and eosin (H&E) and imaged using a Leica TSC
SP2 microscope. For quantification of adipocyte size distribution, a
minimum of three sections per mouse across adipose tissue depot
(332–551 adipocytes) were analyzed. Adipocyte pixel area was
measured using Fiji software (ImageJ) and converted to adipocyte
diameter.
For immunodetection, mouse brains were dissected from 6- to
10-week-old intracardially perfused mice. After post-fixation (24 h)
and cryopreservation in 30% sucrose/PBS, brains were cut in 30-lm-
thick coronal sections using a sliding microtome. Free-floating
sections across the arcuate nucleus were stained for KLF4 (Cat No
4038, Cell Signaling; dilution 1:500). Primary antibodies were visual-
ized using Alexa Fluor 555 secondary antibody conjugates. AgRP/
NPY neurons were identified by native hrGFP fluorescence from the
Npy-GFPTg/ transgene. Images were acquired using confocal laser
scanning microscope (Zeiss NLO 710). KLF4-positive areas were
quantified as percentage of GFP-positive area using Fiji software
(ImageJ). For quantification of KLF-positive area, two sections per
mouse in the middle part of the arcuate nucleus (the region 1.82–
1.94 mm caudal to bregma) were analyzed. The total number of
AgRP/NPY neurons in the arcuate nucleus was obtained by manual
count of all GFP-positive cell bodies in every forth section of the
nucleus and subsequent multiplication times four.
The following additional antibodies were used in this study for
immunohistology and Western blot analyses: SORCS1 (NoNBP1-
86096, Novus Biologicals; dilution 1:200), SORCS3 (MAB3067, R&D
Systems; dilution 1:200), KLF4 (No 4038, Cell Signaling; dilution
1:500), pTrkA/pTrkB (Y706/707) (No 4621, Cell Signaling; dilution
1:1,000), TrkB (No ab18987, Abcam; dilution 1:1,000), tubulin (No
CP06, EMD Millipore; 1:5,000), GAPDH (No ab9484, Abcam; dilu-
tion 1:1,000), PSD95 (No 3409, Cell Signaling; dilution 1:1,000),
synaptophysin (No 101011, Synaptic Systems; dilution 1:5,000),
Golgin 97 (No 13192, Cell Signaling; dilution 1:1,000).
In situ hybridization
Adult female C57BL/6J mice were sacrificed by cervical luxation,
and brains flash-frozen using liquid nitrogen and stored at 80°C
until cryosectioning. In vitro transcription and RNA labeling with
a-35S-UTP was performed according to the manufacturer’s instruc-
tions (Promega, Madison, WI). In situ hybridizations were
performed as described before [12]. In brief, 20-lm parallel coronal
cryosections were fixed, acetylated, dehydrated, subjected to
in situ hybridization at 55°C for 18 h, followed by RNAseA treat-
ment and a high stringency wash in 0.1× saline sodium citrate
buffer at 55°C. After dehydration slides were exposed to X-ray
films for 1–14 days. All ISH probes were cloned into pBSK (Strata-
gene, La Jolla, CA) and comprised the following nucleotides:
SorCS1, 1023–1545 (NM_021377); SorCS3, 1850–2521 (AF276314);
NPY, 1–491 (BC043012); and AgRP, 86–586 (NM_007427.3).
Brain membrane fractionation
Brain subcellular fractionations were performed according to a
protocol adapted from [66,67]. In brief, brains from 7- to 12-week-
old mice were homogenized in HEPES-buffered sucrose (0.32 M
sucrose, 4 mM HEPES, protease, and phosphatase inhibitors, pH
7.4). Nuclear fractions were removed by centrifugation (1,000× g
10 min) and post-nuclear supernatant (S1) further centrifuged
(10,000× g 15 min) to pellet the crude synaptosomal fraction (P2).
The resulting supernatant was subjected to ultracentrifugation
(150,000× g 30 min) to yield the light membrane-enriched fraction
(P3). The P2 fraction was washed in HEPES-buffered saline,
subjected to hypo-osmotic lysis in 4 mM HEPES and subsequent
centrifugation (25,000× g 20 min) to pellet the synaptosomal
membrane fraction (LP1). The corresponding supernatant was
centrifuged (165,000× g 2 h) to obtain synaptic vesicles fraction
(LP2). LP1 pellet was resuspended in HEPES-buffered saline and
layered on top of discontinuous sucrose gradient. The gradient was
centrifuged (150,000× g 2 h) to recover synaptic plasma membranes
(SPM) at the interphase between 1.0 and 1.2 M sucrose. The SPM
fraction was further solubilized in 50 mM HEPES containing 0.5%
Triton X-100. Post-synaptic density membranes (PSD) were pelleted
by centrifugation (200,000× g 20 min) from the solubilized SPM.
Primary cortical and hypothalamic neurons
Primary cortical and hypothalamic neurons were prepared from
newborn S1/3 KO and WT mice using enzymatic digestion with
papain. Neurons were plated on poly-D-lysine-coated plates
(0.8 × 106 live cells/cm2 for cortical neurons, 0.4 × 106 live cells/
cm2 for hypothalamic neurons). Neurons were maintained in Neuro-
basal medium (Invitrogen) supplemented with B27, GlutaMAX, and
penicillin/streptomycin (Invitrogen). Medium for hypothalamic
neurons was additionally supplemented with 5% heat-inactivated
horse serum and cytosine b-d-arabinofuranoside (AraC, added on
DIV3 at 1 lM). The medium for cortical neurons was not replaced
during the entire culture period but the medium for hypothalamic
neurons was renewed every 3 days by replacing 50% with fresh
medium. Where stated, neurons were stimulated with recombinant
BDNF (R&D Systems) added to the conditioned medium at a final
concentration 100 ng/ml. Neurons were lysed at the indicated time
points for either protein analysis or RNA extraction.
Surface proteome analysis
Mixed hippocampal/cortical neuronal cultures were prepared from
newborn WT or S1/3 KO mice and plated on poly-D-lysine-coated
plates (5 × 106 cells/10-cm plate). Cell surface biotinylation was
performed at DIV10-12 using EZ-LinkTM Sulfo-NHS-SS-Biotin
(Thermo Fisher Scientific) according to published protocols [68].
Biotinylated proteins were pulled down with Neutravidin slurry
(Pierce). After washing, the beads were snap-frozen and stored at
80°C until mass spectrometry analysis. For mass spectrometry,
each sample was run on a stacking SDS–PAGE collecting all proteins
in a single band. After Coomassie staining, the gel pieces were
minced and digested with trypsin in an automated fashion using a
PAL robot (Axel Semrau/CTC Analytics) [69]. Peptides were
extracted with extraction buffer (80% acetonitrile, 0.1% [v/v]
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formic acid) and dried in a speed-vac followed by purification on
C18 stage-tips [70]. The eluted peptides were dried in a speed-vac
and resuspended in 3% acetonitrile, 0.1% (v/v) formic acid for LC-
MS measurement.
The samples were measured by LC-MS/MS on a Q Exactive Plus
mass spectrometer (Thermo) connected to a Proxeon nano-LC
system (Thermo). The peptides were separated on an in-house
prepared nano-LC column (0.074 mm × 250 mm, 3 lm Reprosil
C18, Dr Maisch GmbH) using a flow rate of 0.25 ll/min. MS acqui-
sition was performed at a resolution of 70,000 in the scan range
from 300 to 1,700 m/z. MS2 scans were carried out at a resolution
of 15,500 with the isolation window of 2.0 m/z. Dynamic exclusion
was set to 30 s, and the normalized collision energy was specified
to 26 eV.
For analysis, the MaxQuant software package version 1.5.2.8
[71] was used. A FDR of 0.01 was applied for peptides and proteins,
and the Andromeda search was performed using a Mus musculus
Uniprot database (August 2014). MS intensities were normalized by
the MaxLFQ algorithm implemented in MaxQuant [72]. MaxLFQ-
normalized intensities among the replicates of the groups to be
related were used for statistical comparison. Proteins were consid-
ered as specifically enriched for a group if they fulfilled a defined
fold change (FC) of the averaged normalized intensities (see result
section) and a P-value from a Student’s t-test < 0.05 for comparison
of two groups. For data visualization, the –log10 (P-value) was plot-
ted against the log2 (FC) using R (www.r-project.org).
Acute hypothalamic slices
Brains were dissected from S1/3 KO and WT mice at post-natal day
5 (P5). Tissue blocks containing hypothalami were obtained using
the McIlwain tissue chopper set at 250 lm. Tissue slices were equili-
brated in carbonated artificial cerebral spinal fluid (ACSF) at 37°C
for 45 min, with the incubation medium changed every 15 min.
Thereafter, the slices were stimulated for 1 h with recombinant
BDNF at a final concentration of 200 ng/ml ACSF. Subsequently, the
tissues were lysed in RIPA buffer and analyzed by Western blotting.
Co-immunoprecipitation experiments
Chinese hamster ovary cells were transfected with expression
constructs encoding rat TrkB and murine SORCS1 or SORCS3 using
LipofectamineTM 2000 reagent (Invitrogen). Cells were lysed 48 h
post-transfection in 0.3% CHAPS containing IP-buffer (20 mM
HEPES, 150 mM NaCl). Immunoprecipitation was performed using
anti-TrkB antibody (ab18987, Abcam) for 30 min at 4°C. Antibody/
protein complexes were isolated from the lysates using immobilized
protein G agarose beads and subjected to SDS–PAGE and Western
blotting according to standard protocols.
Fluorescence-activated cell sorting (FACS) of neurons from
mouse brain
Npy-GFP mice were sacrificed after an overnight fast, and the brains
were rapidly extracted. The area containing the arcuate nucleus was
microdissected based on anatomical landmarks. Tissue from 10
mice was pooled. To obtain a single-cell suspension, tissue was
subjected to enzymatic digestion according to the published
protocol using papain dissociation system (Worthington) [73].
GFP+ cells were sorted on a BD FACSAriaTM IIu directly in TRIzol
reagent for subsequent mRNA extraction. The expression of target
genes in GFP+ neurons was related to their general expression in
the arcuate nucleus (i.e., in the dissociated cell suspension taken
before FACS sorting).
Statistical analyses
For all in vivo experiments, an indicated n-number is the number of
mice per group used in an experiment. Each mouse represents a
statistically independent experimental unit, which is treated accord-
ingly as an independent value in the statistical analyses. Statistical
analyses were performed using GraphPad Prism software. For
comparison between the two experimental groups, a two-tailed
unpaired t-test was used. For comparison between three or more
groups, one- or two-way ANOVA with Bonferroni post-test was
applied. Energy expenditure was analyzed by ANCOVA using the
online tool provided by NIDDK Mouse Metabolic Phenotyping
Centers (supported by grant DK076169). The statistical tests used
for the experiments are specified in the respective figure legends.
Expanded View for this article is available online.
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